PL100427B1 - Sposob wytwarzania nowych pochodnych kwasu prostanowego - Google Patents
Sposob wytwarzania nowych pochodnych kwasu prostanowego Download PDFInfo
- Publication number
- PL100427B1 PL100427B1 PL1975179810A PL17981075A PL100427B1 PL 100427 B1 PL100427 B1 PL 100427B1 PL 1975179810 A PL1975179810 A PL 1975179810A PL 17981075 A PL17981075 A PL 17981075A PL 100427 B1 PL100427 B1 PL 100427B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- group
- carbon atoms
- trans
- radical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1749774A GB1458315A (en) | 1974-04-22 | 1974-04-22 | Prostanoic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL100427B1 true PL100427B1 (pl) | 1978-10-31 |
Family
ID=10096210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1975179810A PL100427B1 (pl) | 1974-04-22 | 1975-04-21 | Sposob wytwarzania nowych pochodnych kwasu prostanowego |
Country Status (21)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2907118A1 (de) * | 1979-02-20 | 1980-09-04 | Schering Ag | Neue prostacyclin-derivate und verfahren zu ihrer herstellung |
| JP4834224B2 (ja) | 1999-03-05 | 2011-12-14 | デューク ユニバーシティ | Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体 |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US8722739B2 (en) * | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US8623918B2 (en) * | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3879437A (en) * | 1971-02-02 | 1975-04-22 | Upjohn Co | Prostaglandin F{HD 3{B {331 {0 analogs |
| US3879439A (en) * | 1971-02-02 | 1975-04-22 | Upjohn Co | Prostaglandin F{HD 3{301 {0 {B analogs |
-
1974
- 1974-04-22 GB GB1749774A patent/GB1458315A/en not_active Expired
-
1975
- 1975-03-27 IE IE698/75A patent/IE41535B1/en unknown
- 1975-03-31 US US05/563,454 patent/US4105854A/en not_active Expired - Lifetime
- 1975-04-01 ZA ZA00752022A patent/ZA752022B/xx unknown
- 1975-04-01 CA CA223,529A patent/CA1077034A/en not_active Expired
- 1975-04-16 HU HU75IE00000683A patent/HU172966B/hu unknown
- 1975-04-21 BE BE155615A patent/BE828186A/xx unknown
- 1975-04-21 NL NL7504695A patent/NL7504695A/xx not_active Application Discontinuation
- 1975-04-21 SE SE7504587A patent/SE7504587L/xx unknown
- 1975-04-21 PL PL1975179810A patent/PL100427B1/pl unknown
- 1975-04-21 LU LU72330A patent/LU72330A1/xx unknown
- 1975-04-21 DD DD185577A patent/DD118410A5/xx unknown
- 1975-04-21 FR FR7512340A patent/FR2267768B1/fr not_active Expired
- 1975-04-21 NO NO751420A patent/NO751420L/no unknown
- 1975-04-22 AT AT753071A patent/ATA307175A/de not_active Application Discontinuation
- 1975-04-22 FI FI751207A patent/FI751207A7/fi not_active Application Discontinuation
- 1975-04-22 ES ES436832A patent/ES436832A1/es not_active Expired
- 1975-04-22 DK DK172875A patent/DK172875A/da active IP Right Grant
- 1975-04-22 CS CS7500002805A patent/CS181781B2/cs unknown
- 1975-04-22 JP JP50049063A patent/JPS50142539A/ja active Pending
- 1975-04-22 DE DE19752517801 patent/DE2517801A1/de not_active Ceased
- 1975-04-22 CS CS7600004538A patent/CS181798B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1077034A (en) | 1980-05-06 |
| BE828186A (fr) | 1975-10-21 |
| FR2267768A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-11-14 |
| JPS50142539A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-11-17 |
| HU172966B (hu) | 1979-01-28 |
| DK172875A (da) | 1975-10-23 |
| AU7992975A (en) | 1976-10-14 |
| US4105854A (en) | 1978-08-08 |
| NO751420L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-10-23 |
| LU72330A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1976-08-19 |
| CS181781B2 (en) | 1978-03-31 |
| NL7504695A (nl) | 1975-10-24 |
| GB1458315A (en) | 1976-12-15 |
| DD118410A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1976-03-05 |
| FI751207A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1975-10-23 |
| DE2517801A1 (de) | 1975-10-30 |
| FR2267768B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1978-08-11 |
| SE7504587L (sv) | 1975-10-23 |
| ZA752022B (en) | 1976-02-25 |
| ES436832A1 (es) | 1976-12-01 |
| ATA307175A (de) | 1978-06-15 |
| IE41535L (en) | 1975-10-22 |
| IE41535B1 (en) | 1980-01-30 |
| CS181798B2 (en) | 1978-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0299914B1 (de) | 9-Halogen-(Z)-prostaglandinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| EP0030377B1 (de) | 9-Chlor-prostaglandinderivate, Verfahren zur Herstellung und Verwendung als Arzneimittel | |
| EP0198829B1 (de) | 9-halogen-prostaglandinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE2322673A1 (de) | Neue verbindungen vom prostaglandintyp und verfahren zu ihrer herstellung | |
| DE2437388A1 (de) | Prostansaeurederivate | |
| EP0215860B1 (de) | 9-halogenprostaglandine, verfahren zu ihrer herstellung | |
| DE2704933A1 (de) | Prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14 und verfahren zu ihrer herstellung | |
| DE2423155A1 (de) | 5-oxa-prostaglandine und verfahren zu deren herstellung | |
| EP0069696A2 (de) | 9-Fluor-prostaglandinderivate, Verfahren zur Herstellung und Verwendung als Arzneimittel | |
| DE2355540C2 (de) | 16-Phenoxy-ω-tetranorprostaglandinderivate | |
| DE2317019A1 (de) | Neue 4,5-didehydro-prostaglandine | |
| PL100427B1 (pl) | Sposob wytwarzania nowych pochodnych kwasu prostanowego | |
| DE2626888A1 (de) | 11-desoxy-16-aryloxy-omega-tetranorprostaglandine | |
| DE2423156A1 (de) | 5-oxa-prostaglandine und verfahren zu deren herstellung | |
| DE2729960A1 (de) | Neue acetylenprostaglandine und verfahren zu ihrer herstellung | |
| DE2830079A1 (de) | Neue prostaglandinderivate der delta 2,4-11-desoxy-pge-reihe | |
| CH634831A5 (en) | Process for the preparation of optically active or racemic prostaglandins. | |
| DE2737808A1 (de) | 2-substituierte aryl-heterocyclische omega-pentanorprostaglandine | |
| DE2610718A1 (de) | Neue 16-phenoxy-prostaglandin-verbindungen | |
| EP0069049B1 (de) | Delta 8,9-Prostaglandinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
| US3959263A (en) | Prostaglandin intermediate | |
| US4091015A (en) | 15-Substituted prostanoic acids | |
| CH624929A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE2644972A1 (de) | Thiaprostaglandine | |
| DE2704932A1 (de) | Prostaglandin-analoga mit dreifachbindung zwischen c-13 und c-14 und verfahren zu ihrer herstellung |